November 25, 2016 - By Linda Rogers · 0 Comments
The stock of BIOPHAN TECHS INCORPORATED (OTCMKTS:BIPH) registered a decrease of 30.77% in short interest. BIPH’s total short interest was 9,000 shares in November as published by FINRA. Its down 30.77% from 13,000 shares, reported previously. With 65,400 shares average volume, it will take short sellers 0 days to cover their BIPH’s short positions. About 25,000 shares traded hands. Biophan Technologies, Inc. (OTCMKTS:BIPH) has risen 25.00% since April 28, 2016 and is uptrending. It has outperformed by 19.59% the S&P500.
Biophan Technologies, Inc. is a technology development company. The company has a market cap of $143,016. The Firm is focused on developing technologies for the companies in the medical device industry. It currently has negative earnings. It has several areas of technology development and research.
Biophan Technologies, Inc., incorporated on January 13, 2000, is a technology development company. The Firm is focused on developing technologies for the companies in the medical device industry. It has several areas of technology development and research.
More notable recent Biophan Technologies, Inc. (OTCMKTS:BIPH) news were published by: Prnewswire.com which released: “Global Coatings for Medical Devices Industry” on November 24, 2016, also Medgadget.com with their article: “Nanocapsules Market â€“ Global Industry Analysis, Size, Share, Growth, Trends …” published on July 17, 2015, Globenewswire.com published: “Inferior Vena Cava (IVC) Filters – Global Trends, Estimates and Forecasts …” on December 12, 2014. More interesting news about Biophan Technologies, Inc. (OTCMKTS:BIPH) were released by: Businesswire.com and their article: “Research and Markets: Global Coatings for Medical Devices Market 2014-2020 …” published on May 14, 2014 as well as Medgadget.com‘s news article titled: “Biothermal Power Source for Implantable Devices” with publication date: November 14, 2005.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Linda Rogers